Psychotropic Drugs

"Psychotropic Drugs" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents).

Descriptor ID	D011619
MeSH Number(s)	D27.505.954.427.700
Concept/Terms	Psychotropic Drugs Psychotropic Drugs Drugs, Psychotropic Psychopharmaceuticals Psychoactive Agents Agents, Psychoactive Psychoactive Drugs Drugs, Psychoactive

Below are MeSH descriptors whose meaning is more general than "Psychotropic Drugs".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Central Nervous System Agents [D27.505.954.427]
Psychotropic Drugs [D27.505.954.427.700]

Below are MeSH descriptors whose meaning is related to "Psychotropic Drugs".

Below are MeSH descriptors whose meaning is more specific than "Psychotropic Drugs".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Psychotropic Drugs" by people in this website by year, and whether "Psychotropic Drugs" was a major or minor topic of these publications.

Bar chart showing 70 publications over 29 distinct years, with a maximum of 7 publications in 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	0	1
1996	0	1	1
1997	1	0	1
1998	1	0	1
1999	1	0	1
2000	0	1	1
2001	1	0	1
2003	0	1	1
2004	1	0	1
2005	0	1	1
2006	0	4	4
2007	3	1	4
2008	0	2	2
2009	2	4	6
2010	1	0	1
2011	2	1	3
2012	2	1	3
2013	1	0	1
2014	3	0	3
2015	3	1	4
2016	5	0	5
2017	7	0	7
2018	1	1	2
2019	3	0	3
2020	3	1	4
2021	1	2	3
2022	0	1	1
2024	1	2	3
2025	1	0	1

Below are the most recent publications written about "Psychotropic Drugs" by people in Profiles.

Krotulski AJ, Mata DC, Smith CR, Palmquist-Orlando KB, Modell C, Vikingsson S, Truver MT. Advances in analytical methodologies for detecting novel psychoactive substances: a review. J Anal Toxicol. 2025 Mar 10; 49(3):152-169.

View in: PubMed
Bergh MS, Bogen IL, Grafinger KE, Huestis MA, ?iestad ?ML. Metabolite markers for three synthetic tryptamines N-ethyl-N-propyltryptamine, 4-hydroxy-N-ethyl-N-propyltryptamine, and 5-methoxy-N-ethyl-N-propyltryptamine. Drug Test Anal. 2024 Dec; 16(12):1544-1557.

View in: PubMed
Bade R, van Herwerden D, Rousis N, Adhikari S, Allen D, Baduel C, Bijlsma L, Boogaerts T, Burgard D, Chappell A, Driver EM, Sodre FF, Fatta-Kassinos D, Gracia-Lor E, Gracia-Mar?n E, Halden RU, Heath E, Jaunay E, Krotulski A, Lai FY, L?ve ASC, O'Brien JW, Oh JE, Pasin D, Castro MP, Psichoudaki M, Salgueiro-Gonzalez N, Gomes CS, Subedi B, Thomas KV, Thomaidis N, Wang D, Yargeau V, Samanipour S, Mueller J. Workflow to facilitate the detection of new psychoactive substances and drugs of abuse in influent urban wastewater. J Hazard Mater. 2024 05 05; 469:133955.

View in: PubMed
Harris-Haman PA. What's New on the Street?: An Update on New Opioids, Psychoactive Drugs, and Synthetic Marijuana. Crit Care Nurs Clin North Am. 2024 Jun; 36(2):211-221.

View in: PubMed
Mohr ALA, Logan BK, Fogarty MF, Krotulski AJ, Papsun DM, Kacinko SL, Huestis MA, Ropero-Miller JD. Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review. J Anal Toxicol. 2022 Jul 14; 46(6):e116-e185.

View in: PubMed
Rodrigues TB, Morais DR, Gianvecchio VAP, Aquino EM, Cunha RL, Huestis MA, Costa JL. Development and Validation of a Method for Quantification of 28 Psychotropic Drugs in Postmortem Blood Samples by Modified Micro-QuEChERS and LC-MS-MS. J Anal Toxicol. 2021 Aug 14; 45(7):644-656.

View in: PubMed
da Cunha KF, Oliveira KD, Cardoso MS, Arantes ACF, Coser PHP, Lima LN, Maluf ACS, Comis MAC, Huestis MA, Costa JL. Prevalence of new psychoactive substances (NPS) in Brazil based on oral fluid analysis of samples collected at electronic music festivals and parties. Drug Alcohol Depend. 2021 10 01; 227:108962.

View in: PubMed
Barenholtz E, Krotulski AJ, Morris P, Fitzgerald ND, Le A, Papsun DM, Logan BK, Hahn WE, Goldberger BA, Cottler LB, Palamar JJ. Online surveillance of novel psychoactive substances (NPS): Monitoring Reddit discussions as a predictor of increased NPS-related exposures. Int J Drug Policy. 2021 12; 98:103393.

View in: PubMed
Malaca S, Lo Faro AF, Tamborra A, Pichini S, Busard? FP, Huestis MA. Toxicology and Analysis of Psychoactive Tryptamines. Int J Mol Sci. 2020 Dec 04; 21(23).

View in: PubMed
da Cunha KF, Oliveira KD, Huestis MA, Costa JL. Screening of 104 New Psychoactive Substances (NPS) and Other Drugs of Abuse in Oral Fluid by LC-MS-MS. J Anal Toxicol. 2020 Oct 12; 44(7):697-707.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement